Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OliNano SEAL vs Curodont D'Senz in Treatment of Dentin Hypersensitivity
NCT05122312Phase 4Completed
- Sponsor
- Al-Azhar University
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Peptides, Hydrogel Systems, Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Olinanoseal and Curodont D'Senz in dentin hypersensitivity (DH) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Dentin Hypersensitivity Assessment at 2 minutes. Started Apr 2020; status: completed.
02
Drugs
OlinanosealCurodont D'Senz
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT05122312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122312.